PERRIGO Co plc
For the period ended Jun 28, 2025. Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 28, 2025 · Filed Aug 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Revenue Recognition
NOTE 2 -REVENUE RECOGNITION
The following is a summary of our net sales by category (in millions):
| Three Months Ended | Six Months Ended | |||
|---|---|---|---|---|
| June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | |
| CSCA | ||||
| Upper Respiratory | $123.3 | $118.8 | $261.2 | $249.1 |
| Digestive Health | 109.7 | 126.0 | 212.7 | 248.2 |
| Nutrition | 95.6 | 86.1 | 200.3 | 176.7 |
| Pain and Sleep-Aids | 80.2 | 81.6 | 156.8 | 164.2 |
| Healthy Lifestyle | 73.7 | 69.1 | 144.1 | 140.4 |
| Oral Care | 60.0 | 73.2 | 122.0 | 137.9 |
| Skin Care | 57.8 | 57.1 | 106.3 | 106.7 |
| Women's Health | 18.7 | 16.8 | 33.7 | 44.0 |
| Vitamins, Minerals, and Supplements ("VMS") | 2.1 | 5.3 | 3.8 | 9.5 |
| Other CSCA(1) | 0.9 | 0.1 | 1.8 | 1.6 |
| Total CSCA | $622.0 | $634.1 | $1,242.8 | $1,278.3 |
| CSCI | ||||
| Skin Care | $122.9 | $127.7 | $234.4 | $242.4 |
| Pain and Sleep-Aids | 63.5 | 50.3 | 117.1 | 101.7 |
| Healthy Lifestyle | 60.7 | 57.5 | 127.3 | 122.1 |
| Upper Respiratory | 55.4 | 50.7 | 128.9 | 119.8 |
| Women's Health | 41.1 | 36.9 | 73.5 | 68.9 |
| VMS | 38.6 | 39.9 | 76.2 | 84.5 |
| Oral Care | 25.2 | 23.0 | 47.7 | 51.7 |
| Digestive Health | 9.9 | 8.5 | 19.5 | 18.0 |
| Other CSCI(1) | 16.9 | 36.8 | 32.8 | 60.1 |
| Total CSCI | $434.3 | $431.3 | $857.4 | $869.3 |
| Total net sales | $1,056.3 | $1,065.5 | $2,100.2 | $2,147.5 |
(1) Consists primarily of other miscellaneous or otherwise uncategorized product lines, none of which is greater than 10% of the segment net sales.
The following table provides information about contract assets from contracts with customers (in millions):
| Balance Sheet Location | June 28, 2025 | December 31, 2024 | |
|---|---|---|---|
| Short-term contract assets | Prepaid expenses and other current assets | $28.4 | $43.9 |
Note 2
We generated net sales in the following geographic locations(1) (in millions):
| Three Months Ended | Six Months Ended | |||
|---|---|---|---|---|
| June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | |
| U.S. | $610.9 | $627.8 | $1,220.2 | $1,260.1 |
| Europe(2) | 421.7 | 408.4 | 833.9 | 828.1 |
| All other countries(3) | 23.7 | 29.3 | 46.1 | 59.3 |
| Total net sales | $1,056.3 | $1,065.5 | $2,100.2 | $2,147.5 |
(1) The net sales by geography are derived from the location of the entity that sells to a third party.
(2) Includes Ireland net sales of $9.8 million and $20.8 million for the three and six months ended June 28, 2025, and $11.4 million and $15.7 million for the three and six months ended June 29, 2024.
(3) Includes net sales generated primarily in Australia and Canada.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.